Evidence-based·Updated November 19, 2026·How we grade evidence

KPV

PeptideResearch peptide

KPV is a three-amino-acid fragment of the hormone alpha-MSH. In mice it reduced experimental colitis when added to drinking water, and in lab tests it calmed inflammatory signals. It has never been tested in a published human study by any route, and FDA found no human exposure data, no toxicity studies in animals and no adverse event reports. A draft HHS policy from October 2026 says HHS does not intend to take enforcement action against compounding of topical and oral KPV acetate by licensed parties under listed conditions, which is not an approval.

Taking KPV with other supplements or medications?Check your whole list for interactions. Free, no account.

Research compound: not an approved drug or dietary supplement

This compound is sold for research and is not FDA-approved for human use or as a dietary supplement. Human evidence is limited; purity and dosing of consumer products are unverified. The data below is an evidence review for education only. Talk to a clinician before considering it.

Quick decision guide

May help most

No approved or proven use

Common dosing range

No approved or established dose. KPV has never been given to people in a published study

When to expect effects

Not established in people

Watch out for

Not FDA-approved; FDA found no human exposure data by any route and no animal toxicity studies, so its safety in people is unknown; online and "research use only" products are unverified

What is it

KPV is a lab-made tripeptide: three amino acids, lysine, proline and valine (Lys-Pro-Val). It copies the last three amino acids (positions 11 to 13) of alpha-melanocyte stimulating hormone (alpha-MSH), a natural hormone with anti-inflammatory effects. FDA found it promoted online as injections, oral products, creams and nasal sprays for gut inflammation, skin conditions and wound healing. It is not FDA-approved for any use, it is not a component of any approved drug, and FDA's 2026 review found no published study in which KPV was given to people by any route. FDA's compounding safety page lists KPV among bulk substances previously in category 2 (may present significant safety risks) whose nominations were withdrawn, and says FDA has not identified any human exposure data and lacks important information on whether it would cause harm (content current as of April 22, 2026). In its briefing document for the July 23-24, 2026 meeting of its Pharmacy Compounding Advisory Committee, FDA wrote that "we propose not adding" KPV to the list of bulk substances pharmacies may use in compounding. On October 30, 2026, the Department of Health and Human Services (the Secretary's office, not FDA) published a DRAFT enforcement discretion policy (91 FR 68526) that lists KPV in its Appendix A: HHS says it does not intend to take enforcement action against a state-licensed pharmacy, federal facility or licensed physician compounding a drug with it under listed conditions; the policy document limits KPV acetate to topical and oral forms. The notice says the draft "does not establish any rights for any person and is not binding on HHS or the public", and HHS may revisit it. It is not an FDA approval, and it applies only to compounding by those licensed parties, not to "research use only" products sold online.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You have inflammatory bowel disease, psoriasis, eczema or a slow-healing wound and want to ask a doctor about the many approved treatments with proven benefit
A registered clinical trial of KPV becomes available and you qualify; none was listed on ClinicalTrials.gov on November 19, 2026

Probably skip if…

You want to treat colitis, Crohn's disease or another gut condition: KPV has only been tested in mice, and stopping or delaying proven treatment for these diseases can be dangerous
You want it for skin, wounds, histamine problems, mast cell activation or "gut repair": KPV has not been tested in people for any of these
You would be buying injections, capsules or nasal sprays online, including "research use only" products: their identity, purity and sterility are unverified
You are pregnant, breastfeeding or planning a pregnancy: there are no human or animal reproductive data

Evidence at a glance

experimental colitis in mice

Mixed Evidence
Effect
Less colon inflammation and faster weight recovery than untreated mice
Best fit
None in people
Time
Days in mice

Evidence for 1 use

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

experimental colitis in mice

Mechanism only
Mixed Evidence

In mice with chemically induced colitis (DSS and TNBS models), KPV added to the drinking water reduced inflammation and inflammatory cytokine levels, and in cell studies nanomolar amounts blocked NF-kappaB and MAP kinase signaling after entering cells through the PepT1 transporter. A second group found that KPV-treated mice with DSS colitis or T-cell transfer colitis recovered body weight sooner and had less inflammation in the colon, and in mice lacking a working melanocortin-1 receptor, KPV treatment prevented death from DSS colitis in all treated animals, suggesting it works at least partly without that receptor. These are mouse results and have never been tested in people: FDA's 2026 review found no human study of KPV by any route.

Effect size
Less colon inflammation and faster weight recovery than untreated mice
Time to effect
Days in mice
Best fit
None in people
Less likely
People with ulcerative colitis or Crohn's disease, who have not been studied

Bottom line: KPV reduced colitis in mice, but it has never been tested in people.

How it works

Unlike its parent hormone, KPV does not appear to act through melanocortin receptors: in lab studies it did not displace alpha-MSH from them and did not trigger their signal in cells carrying the pigment receptor (MC1). In cells it reduced NF-kappaB, a master switch for inflammatory signals, and in human gut cells it entered through PepT1, a transporter that carries small peptides and is increased in the colon during inflammatory bowel disease. FDA notes that its actual molecular target is still unknown. When applied to human skin from donors in the lab, KPV did not pass through the skin in detectable amounts on its own; only physical methods such as microneedles or a small electric current (iontophoresis) moved it into deeper layers. That limits how much a plain cream could deliver. No study has measured how much reaches the blood in people by any route.

How to take it

1. Typical dose
There is no approved or established dose. FDA found no published study in which KPV was given to people, so there is no studied human dose. The compounding nomination FDA reviewed proposed a 0.1% cream or gel, which is a proposal, not a tested dose.
2. Higher studied dose
Not established in people.
3. Timing
Not established.
4. With food
Not established.
5. Split dosing
Not established.
6. How long to try
No human data at any duration.

What to track

If you have used it: tell your doctor and pharmacist
For gut conditions: worsening diarrhea, blood in the stool, fever or belly pain need prompt medical care, whatever you are taking
Injection-site redness, swelling or pus, or skin irritation where a cream was applied
Hives, facial swelling or trouble breathing: get emergency care

Bottom line: No human dose has ever been tested; products sold today are untested in people.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Unknown: KPV has never been given to people in a published study, so no side-effect profile existsInjection-site reactions and infection are possible with any injected product of unknown sterility

Serious risks

Who should avoid it

Pregnancy & breastfeeding

There are no human data on KPV in pregnancy or breastfeeding, and FDA found no animal studies of its effects on reproduction or development. Avoid use if you are pregnant, breastfeeding or planning a pregnancy, and talk to your doctor.

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

There is no FDA-approved KPV product, so no label can show FDA approval
Compounded drugs are not FDA-approved: FDA does not review their safety, effectiveness or quality before they are sold, even under the October 2026 draft HHS policy
Under that draft policy, compounded KPV would be KPV acetate as the only active ingredient, in a topical or oral form, labeled "This is a compounded drug product. Not for resale."

Be skeptical of…

"Heals the gut", "treats colitis or Crohn's" or "repairs leaky gut": shown only in mice
"Clinically proven anti-inflammatory": no human study exists
"Treats mast cell activation, histamine intolerance, Lyme disease or mold illness": FDA found no study of KPV in people for any use
"FDA-approved" or "FDA-cleared" KPV: no KPV product is approved, and the 2026 HHS policy is a draft about enforcement, not an approval
"Works like alpha-MSH" or "melanocortin peptide": KPV did not displace alpha-MSH from melanocortin receptors in lab studies, and FDA notes these receptors are unlikely to explain its effects
"For research use only" vials or nasal sprays sold to consumers: unapproved, untested and not covered by the HHS policy

Frequently asked questions

Is KPV FDA-approved?⌄

No. No KPV product is approved by FDA, and FDA's 2026 review found no authorized product in the European Union. FDA's compounding safety page lists it among substances previously in category 2 (may present significant safety risks) whose nominations were withdrawn.

What did HHS announce about KPV in October 2026?⌄

On October 30, 2026, HHS published a draft enforcement discretion policy (91 FR 68526) that lists KPV with five other peptides. HHS says it does not intend to take enforcement action against a state-licensed pharmacy, federal facility or licensed physician compounding a drug with KPV for an individual patient with a valid prescription, if conditions are met, such as an FDA-registered manufacturer, a certificate of analysis, a single active ingredient and reporting of serious adverse events. The policy document limits KPV acetate to topical and oral forms, so it does not cover injections or nasal sprays. The notice says the draft "does not establish any rights for any person and is not binding on HHS or the public", and HHS may revisit it. It is not an FDA approval.

Has KPV been tested in people?⌄

No. FDA's 2026 review found no published study in which KPV was given to people by any route, and no clinical trial of KPV was listed on ClinicalTrials.gov on November 19, 2026. The evidence comes from mouse colitis models and cell studies.

Is KPV the same as melanotan or a tanning peptide?⌄

No. KPV is a different peptide, a three-amino-acid piece of the hormone alpha-MSH; FDA lists melanotan II as a separate substance on its compounding safety page. In lab studies KPV did not displace alpha-MSH from melanocortin receptors, including in cells carrying the skin pigment receptor (MC1), and FDA's review notes these receptors are unlikely to explain its effects.

Can I take KPV with my supplements or medicines?⌄

No interaction studies exist, and KPV has never been studied in people. If you take medicines for inflammatory bowel disease or a skin condition, talk to your doctor before making any change. Ask a doctor or pharmacist to review your full list.

References by claim

experimental colitis in mice

Dalmasso et al., 2008 · PMC (2008) link

Kannengiesser et al., 2008 · PubMed (2008) link

Safety

FDA briefing document for the July 23-24, 2026 Pharmacy Compounding Advisory Committee: KPV-related bulk drug substances · FDA link

FDA: Certain bulk drug substances for use in compounding that may present significant safety risks · FDA link

Federal Register, October 30, 2026 (91 FR 68526): Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances · HHS link

Track KPV with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 19, 2026·Evidence current as of Nov 19, 2026·How we grade evidence

Disclaimer: This compound is not approved by the FDA for human use and is not a dietary supplement. This page is an educational review of available research (much of it preclinical or early-stage), not a recommendation to use it. Consumer product quality is unregulated. Consult a qualified clinician.